IRIDEX Corporation (IRIX) P/E Ratio History
Deep ValueTrading at -4.3x · 0th percentile of 5-year range · Significant discount to historical valuation · Data 1997–2016
Loading P/E history...
P/E Ratio Analysis
As of June 28, 2026, IRIDEX Corporation (IRIX) trades at a price-to-earnings ratio of -4.3x, with a stock price of $1.13 and trailing twelve-month earnings per share of $-0.19.
The current P/E is 106% below its 5-year average of 72.5x. Over the past five years, IRIX's P/E has ranged from a low of 8.6x to a high of 401.6x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 23.0x, IRIX trades at a 119% discount to its sector peers. The sector includes 231 companies with P/E ratios ranging from 0.0x to 191.4x.
Relative to the broader market, IRIX trades at a notable discount to the S&P 500 median P/E of 25.3x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our IRIX DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
IRIX Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
IRIX P/E vs Peers
Vision, dental, and ENT devices peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $13B | 31.6 | - | +1% | |
| $17B | 30.5Lowest | - | -25% | |
| $144B | 51.4 | 2.36Best | +23% | |
| $127B | 39.6 | 2.66 | +8% | |
| $52B | 49.6 | 7.01 | -74% | |
| $27B | 33.6 | 3.20 | +47%Best |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
IRIX Historical P/E Data (1997–2016)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2016 Q2 | Jul 02 2016 | $15.51 | $0.06 | 269.7x | +364% |
| FY2016 Q1 | Apr 02 2016 | $10.04 | $0.03 | 401.6x | +591% |
| FY2015 Q4 | - | $9.29 | $0.04 | 265.4x | +356% |
| FY2015 Q3 | Oct 03 2015 | $7.37 | $0.85 | 8.6x | -85% |
| FY2015 Q2 | Jul 04 2015 | $8.22 | $0.86 | 9.5x | -84% |
| FY2015 Q1 | Apr 04 2015 | $10.70 | $0.96 | 11.1x | -81% |
| FY2014 Q4 | Dec 31 2014 | $8.60 | $0.99 | 8.7x | -85% |
| FY2014 Q3 | Sep 27 2014 | $7.13 | $0.17 | 41.9x | -28% |
| FY2014 Q2 | Jun 28 2014 | $8.28 | $0.17 | 48.7x | -16% |
| FY2014 Q1 | Mar 29 2014 | $8.58 | $0.18 | 47.7x | -18% |
| FY2013 Q4 | - | $10.17 | $0.22 | 46.2x | -21% |
| FY2013 Q3 | Sep 28 2013 | $6.08 | $0.20 | 30.4x | -48% |
| FY2013 Q2 | Jun 29 2013 | $5.91 | $0.07 | 87.8x | +51% |
| FY2013 Q1 | Mar 30 2013 | $4.45 | $0.06 | 77.7x | +34% |
| FY2012 Q4 | Dec 31 2012 | $3.90 | $0.15 | 26.5x | -54% |
| FY2012 Q3 | Sep 29 2012 | $3.70 | $0.21 | 17.2x | -70% |
| FY2012 Q2 | Jun 30 2012 | $4.17 | $0.33 | 12.7x | -78% |
| FY2012 Q1 | Mar 31 2012 | $4.41 | $0.39 | 11.4x | -80% |
| FY2011 Q4 | Dec 31 2011 | $3.74 | $0.27 | 14.0x | -76% |
| FY2011 Q3 | Oct 01 2011 | $3.70 | $0.27 | 13.5x | -77% |
| FY2011 Q2 | Jul 02 2011 | $3.95 | $0.33 | 11.8x | -80% |
| FY2011 Q1 | Apr 02 2011 | $4.65 | $0.32 | 14.4x | -75% |
| FY2010 Q4 | Dec 31 2010 | $3.92 | $0.31 | 12.5x | -79% |
| FY2010 Q3 | Oct 02 2010 | $3.51 | $0.28 | 12.6x | -78% |
| FY2010 Q2 | Jul 03 2010 | $3.81 | $0.26 | 14.7x | -75% |
| FY2010 Q1 | Apr 03 2010 | $4.25 | $0.30 | 14.2x | -76% |
| FY2009 Q4 | - | $3.07 | $0.27 | 11.4x | -80% |
| FY2006 Q2 | Jul 01 2006 | $9.79 | $0.06 | 170.0x | +192% |
| FY2006 Q1 | Apr 01 2006 | $12.24 | $0.18 | 69.2x | +19% |
| FY2005 Q4 | Dec 31 2005 | $7.86 | $0.21 | 37.6x | -35% |
| FY2005 Q3 | Oct 01 2005 | $8.80 | $0.05 | 186.0x | +220% |
| FY2004 Q2 | Jul 03 2004 | $7.00 | $0.13 | 55.1x | -5% |
| FY2004 Q1 | Apr 03 2004 | $9.17 | $0.06 | 143.7x | +147% |
| FY2003 Q4 | Dec 31 2003 | $5.45 | $0.05 | 100.4x | +73% |
| FY2003 Q3 | Sep 27 2003 | $4.40 | $0.07 | 61.6x | +6% |
| FY2003 Q2 | Jun 28 2003 | $3.59 | $0.06 | 58.5x | +1% |
| FY2003 Q1 | Mar 29 2003 | $3.62 | $0.04 | 91.9x | +58% |
| FY2002 Q4 | - | $2.90 | $0.02 | 138.1x | +137% |
| FY2002 Q1 | Mar 30 2002 | $4.67 | $0.04 | 104.0x | +79% |
| FY2000 Q4 | Dec 31 2000 | $4.88 | $0.35 | 13.8x | -76% |
| FY2000 Q3 | Sep 30 2000 | $10.94 | $0.43 | 25.4x | -56% |
| FY2000 Q2 | Jul 01 2000 | $12.75 | $0.40 | 31.9x | -45% |
| FY2000 Q1 | Apr 01 2000 | $11.75 | $0.35 | 33.6x | -42% |
| FY1999 Q4 | Dec 31 1999 | $8.63 | $0.27 | 31.9x | -45% |
| FY1999 Q3 | Oct 02 1999 | $4.25 | $0.20 | 20.7x | -64% |
| FY1999 Q2 | Jul 03 1999 | $4.50 | $0.17 | 27.3x | -53% |
| FY1999 Q1 | Apr 03 1999 | $4.25 | $0.20 | 21.8x | -63% |
| FY1998 Q4 | - | $4.25 | $0.27 | 16.0x | -72% |
| FY1998 Q3 | Oct 03 1998 | $3.75 | $0.31 | 12.1x | -79% |
| FY1998 Q2 | Jul 04 1998 | $7.88 | $0.39 | 20.2x | -65% |
| FY1998 Q1 | - | $8.31 | $0.39 | 21.3x | -63% |
| FY1997 Q4 | Dec 31 1997 | $7.63 | $0.32 | 23.8x | -59% |
| FY1997 Q3 | - | $11.88 | $0.28 | 42.4x | -27% |
| FY1997 Q2 | Jun 30 1997 | $9.13 | $0.23 | 39.7x | -32% |
Average P/E for displayed period: 58.2x
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
29+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
IRIX — Frequently Asked Questions
Quick answers to the most common questions about buying IRIX stock.
What is IRIX's P/E ratio?
IRIDEX Corporation (IRIX) trailing twelve-month P/E ratio is -4.3x, based on TTM diluted EPS of $-0.19. The 5-year average P/E is 72.5x and the historical range spans 8.6x to 401.6x.
Is IRIX stock overvalued or undervalued?
IRIX trades at -4.3x P/E, below its 5-year average of 72.5x. At the 0th percentile of its historical range (8.6x–401.6x), the stock is priced at a discount to its own history.
Is IRIX stock expensive?
No, IRIX is not expensive on a historical basis. The current P/E of -4.3x is below the 5-year average of 72.5x and sits at the 0th percentile of its valuation range.
What is IRIX's historical P/E range?
Over the past 5 years, IRIX's P/E ratio has ranged from 8.6x to 401.6x, with a median of 30.4x and an average of 72.5x. The current P/E of -4.3x places the stock at the 0th percentile of this range. Full historical data spans 1997–2016.
How does IRIX's P/E compare to the S&P 500?
IRIX trades at -4.3x P/E versus the S&P 500 median of 25.3x. The 117% discount to the market suggests lower growth expectations or perceived higher risk.
How does IRIX's valuation compare to Healthcare peers?
IRIDEX Corporation P/E of -4.3x compares to the Healthcare sector median of 23.0x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is IRIX's PEG ratio?
IRIX PEG ratio is N/A, based on a P/E of -4.3x and EPS growth of 51.9%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is IRIX's earnings yield?
IRIX earnings yield is N/A, the inverse of its -4.3x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.